Literature DB >> 14723785

Contralateral tendon rupture risk is increased in individuals with a previous Achilles tendon rupture.

A Arøen1, D Helgø, O G Granlund, R Bahr.   

Abstract

The purpose of this study was to examine the outcome after surgery for an acute Achilles tendon rupture. In particular, we wanted to study whether persons who have suffered an Achilles tendon rupture are at greater risk of a contralateral tendon rupture. From September 1990 to April 1997, 168 acute Achilles tendon ruptures in 26 women and 142 men were treated operatively. In August 1998 (median: 4.2 years post injury), 154 of these patients (92%) responded to a follow-up questionnaire. Local symptoms (pain, decreased strength and/or reduced range of motion) were reported pre injury by 25% of the patients; at follow-up this had increased to 52%. Ten patients (6%) experienced a rupture on the contralateral side during the follow-up period (OR: 176 [70-282] vs. the expected rate based on the general population risk of this injury, P<0.001). Thus, this study suggests that patients with an Achilles tendon rupture are at significantly increased risk of a contralateral tendon rupture, as well. Also, as many as half of the patients suffered from post-injury problems at long-term follow-up.

Entities:  

Mesh:

Year:  2004        PMID: 14723785     DOI: 10.1111/j.1600-0838.2004.00344.x

Source DB:  PubMed          Journal:  Scand J Med Sci Sports        ISSN: 0905-7188            Impact factor:   4.221


  13 in total

Review 1.  The pain of tendinopathy: physiological or pathophysiological?

Authors:  Ebonie Rio; Lorimer Moseley; Craig Purdam; Tom Samiric; Dawson Kidgell; Alan J Pearce; Shapour Jaberzadeh; Jill Cook
Journal:  Sports Med       Date:  2014-01       Impact factor: 11.136

2.  Age is a risk factor for contralateral tendon rupture in patients with acute Achilles tendon rupture.

Authors:  Young Hwan Park; Tae Jin Kim; Gi Won Choi; Hak Jun Kim
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-02-18       Impact factor: 4.342

Review 3.  Tendon and ligament injuries: the genetic component.

Authors:  Alison V September; Martin P Schwellnus; Malcolm Collins
Journal:  Br J Sports Med       Date:  2007-01-29       Impact factor: 13.800

4.  Injury risk is altered by previous injury: a systematic review of the literature and presentation of causative neuromuscular factors.

Authors:  Jessica Fulton; Kathryn Wright; Margaret Kelly; Britanee Zebrosky; Matthew Zanis; Corey Drvol; Robert Butler
Journal:  Int J Sports Phys Ther       Date:  2014-10

5.  Tendinopathy: Investigating the Intersection of Clinical and Animal Research to Identify Progress and Hurdles in the Field.

Authors:  Ashley Titan; Nelly Andarawis-Puri
Journal:  JBJS Rev       Date:  2016-10-11

6.  The repair of the Achilles tendon rupture: comparison of two percutaneous techniques.

Authors:  G Taglialavoro; C Biz; G Mastrangelo; R Aldegheri
Journal:  Strategies Trauma Limb Reconstr       Date:  2011-11-08

7.  Return to play post-Achilles tendon rupture: a systematic review and meta-analysis of rate and measures of return to play.

Authors:  Jennifer A Zellers; Michael R Carmont; Karin Grävare Silbernagel
Journal:  Br J Sports Med       Date:  2016-06-03       Impact factor: 13.800

8.  The seasonal variation of Achilles tendon ruptures in Vancouver, Canada: a retrospective study.

Authors:  Alex Scott; Navdeep Grewal; Pierre Guy
Journal:  BMJ Open       Date:  2014-02-11       Impact factor: 2.692

9.  Do athletes alter their running mechanics after an Achilles tendon rupture?

Authors:  Daniel Jandacka; Julia Freedman Silvernail; Jaroslav Uchytil; David Zahradnik; Roman Farana; Joseph Hamill
Journal:  J Foot Ankle Res       Date:  2017-11-28       Impact factor: 2.303

10.  Spatiotemporal variations in gene expression, histology and biomechanics in an ovine model of tendinopathy.

Authors:  Sara Biasutti; Andrew Dart; Margaret Smith; Carina Blaker; Elizabeth Clarke; Leo Jeffcott; Christopher Little
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.